16 results
10-K
2023 FY
EX-10.23
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
and irreparable harm to the Company. I agree and covenant not to directly or indirectly solicit, hire, recruit, or attempt to solicit, hire, or recruit
10-K
2023 FY
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
which may limit or ability to recruit and enroll new subjects;
difficulties in retaining and following up with subjects and censoring of patients
6-K
ADCT
Adc Therapeutics SA
1 Jun 21
Current report (foreign)
4:42pm
a sales force is expensive and time-consuming and could delay product launch. If the commercial launch of a product candidate for which we recruit … . We must also compete with other biotechnology companies to recruit, hire, train and retain marketing and sales personnel.
Factors that may inhibit
20-F
2020 FY
ADCT
Adc Therapeutics SA
18 Mar 21
Annual report (foreign)
7:12am
is expensive and time-consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force … compete with other biotechnology companies to recruit, hire, train and retain marketing and sales personnel.
Alternatively, we may wish to establish
424B4
4t2kogd5jpw6 ydt
25 Sep 20
Prospectus supplement with pricing info
4:14pm
F-1
8p0jv98juo1e65soa
21 Sep 20
Registration statement (foreign)
4:30pm
DRS
ver pfid9ahjd0sg93
11 Sep 20
Draft registration statement
12:00am
424B4
6hshdr6r bfw87
18 May 20
Prospectus supplement with pricing info
8:52am
F-1/A
n4unm
14 May 20
Registration statement (foreign) (amended)
6:08am
F-1/A
qy1zhxskt3mz364
11 May 20
Registration statement (foreign) (amended)
6:26am
F-1
wh3tzxe3xsno
24 Apr 20
Registration statement (foreign)
5:23pm
DRS
078vzc5myg rq
2 Mar 20
Draft registration statement
12:00am
F-1/A
ocudcd 17s7f
23 Sep 19
Registration statement (foreign) (amended)
6:08am
F-1
9dbp1v825ui n1jj
6 Sep 19
Registration statement (foreign)
5:12pm
DRS
5dwvxm gltzqy0ec214
28 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next